Format

Send to

Choose Destination
Int J Impot Res. 2004 Feb;16(1):95-7.

Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole.

Author information

1
Division of Urology, Beth Israel Deaconess Medical Center, Men's Health Boston, Harvard Medical School, Massachusetts 02445, USA. amorgent@caregroup.harvard.edu

Abstract

Gynecomastia is an unusual side effect associated with testosterone replacement therapy (TRT) that has been traditionally treated with surgery, radiation, or discontinuation of testosterone supplementation. We report here our experience with two cases of gynecomastia in men undergoing TRT who were successfully treated with the aromatase inhibitor anastrozole.

PMID:
14963480
DOI:
10.1038/sj.ijir.3901154
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center